The Valley Desk

NCT06925321 · Interventional trial

A Phase 3 Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult Patients With Invasive Mold Infections.

Overall registry status Recruiting

Phase 3

Conditions Invasive Mold Infections

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov